• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION OBTRYX II SYSTEM - HALO; MESH, SURGICAL, SYNTHETIC, UROGYNECOLOGIC, FOR STRESS URINARY INCONTINENCE, RETR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION OBTRYX II SYSTEM - HALO; MESH, SURGICAL, SYNTHETIC, UROGYNECOLOGIC, FOR STRESS URINARY INCONTINENCE, RETR Back to Search Results
Model Number M0068505110
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Hematoma (1884); Hemorrhage/Bleeding (1888)
Event Date 02/23/2018
Event Type  Injury  
Event Description
It was reported to boston scientific corporation that an obtryx ii system - halo device was implanted into the patient during a laparoscopic vaginal hysterectomy + enterocele repair + anterior and posterior repair + sling cystourethropexy + cystoscopy + bilateral proximal salpingectomy procedure performed on (b)(6) 2018, for the treatment of menorrhagia, severe dysmenorrhea, pelvic relaxation, cystocele, rectocele, stress urinary incontinence, dyspareunia, and retroflexed uterus.The patient was awakened and returned to the recovery room in good condition.On (b)(6) 2018, the patient came back due to vaginal bleeding.An exam under anesthesia and a suture of the vaginal bleeding site was then performed.Clot was removed from the vaginal vault as she was being prepped.There was a bleeding site on the mucosal edge of the upper pole of the posterior vaginal incision.During the surgery, the bleeding site was identified, and the suture ligated with 1 chromic.The patient was awakened and returned to the recovery room in good condition.
 
Manufacturer Narrative
Block e1: this event was reported by the patient's legal representation.The implant and surgical intervention surgeon is: dr.(b)(6).Assistant: dr.(b)(6).(b)(6) medical center.Block h6: imdrf patient codes e0506 and e0505 capture the reportable events of vaginal bleeding and clot in the vaginal vault.Imdrf impact code f19 capture the reportable event of suture of vaginal bleeding site.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OBTRYX II SYSTEM - HALO
Type of Device
MESH, SURGICAL, SYNTHETIC, UROGYNECOLOGIC, FOR STRESS URINARY INCONTINENCE, RETR
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
780 brookside drive
spencer IN 47460
Manufacturer Contact
carole morley
300 boston scientific way
marlborough, MA 01752
5086834015
MDR Report Key17477478
MDR Text Key320569484
Report Number3005099803-2023-04188
Device Sequence Number1
Product Code OTN
UDI-Device Identifier08714729837565
UDI-Public08714729837565
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K121754
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer
Reporter Occupation Other
Type of Report Initial
Report Date 08/07/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date10/10/2020
Device Model NumberM0068505110
Device Catalogue Number850-511
Device Lot Number0021244713
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 07/12/2023
Initial Date FDA Received08/07/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured10/11/2017
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age42 YR
Patient SexFemale
-
-